GeneDx Holdings Corp.
US ˙ NasdaqGS ˙ US81663L2007

SecurityWGS / GeneDx Holdings Corp.
InstitutionBarclays Plc
Latest Disclosed Ownership33,936 shares
Latest Disclosed Value $ 4,413,717
Barclays Plc reports 26.19% decrease in ownership of WGS / GeneDx Holdings Corp.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 33,936 shares of GeneDx Holdings Corp. (US:WGS) valued at $4,413,716 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 45,980 shares of GeneDx Holdings Corp.. This represents a change in shares of -26.19% during the quarter. The current value of the position is $1,771,799 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F GENEDX HOLDINGS COM 81663L200 33,936 -12,044 -26.19 4,414 -10.90 0.0011
2026-03-31 2025-09-30 13F/A-3 GENEDX HOLDINGS COM 81663L200 45,980 -13,425 -22.60 4,954 -9.67 0.0011
2026-03-19 2025-09-30 13F/A-2 GENEDX HOLDINGS COM 81663L200 18,921 -40,484 803 0.0002
2025-11-12 2025-09-30 13F GENEDX HOLDINGS COM 81663L200 45,980 -13,425 4,954 0.0011
2026-02-27 2025-06-30 13F/A-2 GENEDX HOLDINGS COM 81663L200 59,405 -15,475 -20.67 5,484 -17.31 0.0013
2025-08-14 2025-06-30 13F/A-1 GENEDX HOLDINGS COM 81663L200 59,405 -15,475 5 0.0013
2025-08-13 2025-06-30 13F GENEDX HOLDINGS COM 81663L200 59,405 -15,475 5 0.0004
2026-03-17 2025-03-31 13F/A-1 GENEDX HOLDINGS COM 81663L200 74,880 -5,527 -6.87 6,632 7.30 0.0019
2025-05-15 2025-03-31 13F GENEDX HOLDINGS COM 81663L200 74,880 -5,527 7 0.0019
2026-03-19 2024-12-31 13F/A-1 GENEDX HOLDINGS COM 81663L200 80,407 61,486 324.96 6,180 669.61 0.0017
2025-02-13 2024-12-31 13F GENEDX HOLDINGS COM 81663L200 80,407 61,486 6 0.0017
2026-03-31 2024-09-30 13F/A-2 GENEDX HOLDINGS COM 81663L200 18,921 14,681 346.25 803 630.00 0.0002
2024-11-19 2024-09-30 13F/A-1 GENEDX HOLDINGS COM 81663L200 18,921 14,681 1 0.0002
2024-11-15 2024-09-30 13F GENEDX HOLDINGS COM 81663L200 18,921 14,681 1 0.0001
2026-03-23 2024-06-30 13F/A-1 GENEDX HOLDINGS COM 81663L200 4,240 4,240 111 0.0000
2024-08-14 2024-06-30 13F GENEDX HOLDINGS COM 81663L200 4,240 4,240 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.